You are here:Home-Chemical Inhibitors & Agonists-Metabolic Enzyme/Protease-Phospholipase-LYPLAL1-IN-11
LYPLAL1-IN-11

Chemical Structure : LYPLAL1-IN-11

CAS No.: 1966129-74-7

LYPLAL1-IN-11

Catalog No.: PC-62407Not For Human Use, Lab Use Only.

LYPLAL1-IN-11 is a potent, selective, covalent inhibitor of lysophospholipase-like 1 (LYPLAL1) with IC50 of 6 nM.

Packing Price Stock Quantity
10 mg Get quote
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    LYPLAL1-IN-11 is a potent, selective, covalent inhibitor of lysophospholipase-like 1 (LYPLAL1) with IC50 of 6 nM.
    LYPLAL1-IN-11 displays high selectivity against a panel of the broader human serine hydrolase proteome (>30 enzymes).
    LYPLAL1-IN-11 significant increases glucose production in human, rat, mouse hepatocytes.

    Physicochemical Properties

    M.Wt 539.596
    Formula C29H29N7O4
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20 °C 12 Months; 4°C 6 Months
    In Solvent
    -80 °C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    (2R,3R)-1-(3-(4-(2-morpholinopyrimidin-5-yl)phenyl)-1H-1,2,4-triazole-1-carbonyl)-2-phenylpiperidine-3-carboxylic acid

    References

    1. Ahn K, et al. ACS Chem Biol. 2016 Sep 16;11(9):2529-40.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: